# Impact of Forced Diuresis on the Residual Fragment Rate After Flexible Ureteroscopy for Destruction of Kidney Stones With Laser

> **NCT05916963** · PHASE3 · RECRUITING · sponsor: **University Hospital, Tours** · enrollment: 374 (estimated)

## Conditions studied

- Kidney Stone

## Interventions

- **DRUG:** Furosemide 40 mg

## Key facts

- **NCT ID:** NCT05916963
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-04
- **Primary completion:** 2026-04-03
- **Final completion:** 2026-04-03
- **Target enrollment:** 374 (ESTIMATED)
- **Last updated:** 2025-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05916963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05916963, "Impact of Forced Diuresis on the Residual Fragment Rate After Flexible Ureteroscopy for Destruction of Kidney Stones With Laser". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05916963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
